Evidence map›Paper›PMID 41355130›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2025

[Analysis of the impact of tumor diameter on short-term prognosis in patients with hepatitis B-related hepatocellular carcinoma-inducing acute-on-chronic liver failure].

Y H Peng, J Chen, C Li, C D Guan, P Ning, H Li, L L Yan, Y H Wang, H B Su, X Y Liu

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Y H PengSenior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
J ChenSenior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
C LiSenior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
C D GuanSenior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
P NingSenior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
H LiSenior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
L L YanSenior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
Y H WangChinese PLA Medical School, Beijing 100853, China.
H B SuSenior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
X Y LiuSenior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.

Funding

the National Key Research and Development Plan 2022YFC2304402
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute-On-Chronic Liver FailureCarcinoma, HepatocellularHepatitis BLiver NeoplasmsAdultFemaleHumansMaleMiddle AgedPrognosisRetrospective Studies

Identifiers

PMID41355130
PMCPMC12861863

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.